首页> 美国卫生研究院文献>Translational Andrology and Urology >Opioid prescribing after urologic surgery: we are part of the problem and part of the solution—an invited commentary on an opioid prescription for men undergoing minor urologic surgery is associated with an increased risk of new persistent opioid use
【2h】

Opioid prescribing after urologic surgery: we are part of the problem and part of the solution—an invited commentary on an opioid prescription for men undergoing minor urologic surgery is associated with an increased risk of new persistent opioid use

机译:阿片类药物在泌尿外科手术后开处方:我们是问题的一部分也是解决方案的一部分—关于进行小规模泌尿外科手术的男性的阿片类药物处方会增加新的持续使用阿片类药物的风险的邀请评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

According to the United States (US) Center for Disease Control, an estimated 23,200 persons died in the US from prescription opioid overdose between 1999 and 2018 ( ). In 2018 alone almost 15,000 prescription opioid-related deaths occurred, accounting for 32% of all drug overdose deaths ( ). These concerns are not isolated to the US, as demonstrated by the United Nations’ attempts to recognize and act upon global concerns related to drug misuse and abuse ( - ).
机译:根据美国疾病控制中心(US)的估计,在1999年至2018年之间,估计有23,200人死于处方阿片类药物过量()。仅在2018年,就发生了近15,000例与阿片类药物相关的处方死亡,占所有药物过量死亡的32%()。联合国试图认识并采取与毒品滥用和滥用有关的全球性关切(-),证明了这些担忧并非孤立于美国。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号